13F Pro Quality Score

39.2/100

Rank #2,159 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

28.9/100

Profitability

47.8/100

Balance Sheet

60.0/100

Earnings Quality

64.1/100

Free Cash Flow

39.6/100

Institutional Flow

1.5/100

Revenue Scale

16.5/100

Dilution Risk

94.7/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

FONR Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for FONAR CORP (FONR), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FONR at 39.2/100 on a 32-signal composite quality model, placing it at rank #2,159 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (1.5) and revenue scale (16.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), FONAR CORP reports quarterly revenue of $26.5M, net income of $1.6M, an operating margin of 10.7%. Top institutional holders of FONR by reported 13-F value include MONEY CONCEPTS CAPITAL, VANGUARD CAPITAL MANAGEMENT, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. FONR trades on the Nasdaq exchange and files with the SEC under CIK 355019. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FONR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for FONAR CORP directly from SEC EDGAR. FONAR CORP's 13F Pro composite quality score has ranged between 39 and 68 since 2021, currently 39.2 — a declining long-term trajectory across 67 quarterly and live scoring snapshots.

Fun facts about FONAR CORP

Quirks, history, and lore behind FONR — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    A small-cap U.S. healthcare company listed on Nasdaq, headquartered on Long Island, New York.
  • 2
    The Numbers
    Annual revenue in the range of tens of millions of dollars — a true micro-niche player — with a focus on a single medical imaging technology.
  • 3
    The History
    Founded in the 1970s, it was a pioneering force in bringing a revolutionary diagnostic imaging technology out of the lab and into clinical medicine.
  • 4
    The Secret
    Its founder holds patents considered foundational to the entire MRI industry — and the company spent years in patent litigation against much larger rivals.
  • 5
    The Lore
    It claims to have built and installed the world's first commercial MRI scanner, and its founder, Raymond Damadian, famously believed he deserved a Nobel Prize for inventing MRI.
  • 6
    The Giveaway
    This Long Island company literally has MRI baked into its DNA — its name is a portmanteau of "field focusing nuclear magnetic resonance" — and it's still scanning decades later.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$26.5M

Net Income

Q1 2026

$1.6M

Free Cash Flow

Q1 2026

$1.4M

Operating Margin

Q1 2026

10.7%

ROIC

Q1 2026

6.3%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+1.4% YoY
$104.4MFY 2025
FY22 $97.6MFY23 $98.6MFY24 $102.9MFY25 $104.4M

Net Income

-21.1% YoY
$8.3MFY 2025
FY22 $12.4MFY23 $9.4MFY24 $10.6MFY25 $8.3M

Operating Income

FY 2025
FY22 $5.3MFY23 $11.1MFY24 $4.5MFY25

Total Assets

+1.2% YoY
$216.9MFY 2025
FY22 $199.3MFY23 $200.6MFY24 $214.2MFY25 $216.9M

Total Debt

FY 2025
FY22 $235.5KFY23 $246.4KFY24 $207.9KFY25

Op. Cash Flow

-20.1% YoY
$11.3MFY 2025
FY22 $15.3MFY23 $14.5MFY24 $14.1MFY25 $11.3M

Free Cash Flow

-43.7% YoY
$7.5MFY 2025
FY22 $10.7MFY23 $10.1MFY24 $13.3MFY25 $7.5M

Get alerted when FONR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for FONAR CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Companies Similar to FONR

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

BWAY

Brainsway Ltd.

39
AI score
Similar quality profile
AUNA

AUNA S.A.

36
AI score
Similar quality profile
STVN

Stevanato Group S.p.A.

42
AI score
Similar quality profile
GSK

GSK plc

44
AI score
Similar quality profile
APT

ALPHA PRO TECH LTD

46
AI score
Similar quality profile
PHG

KONINKLIJKE PHILIPS NV

40
AI score
Similar quality profile
RVP

RETRACTABLE TECHNOLOGIES INC

24
AI score
Similar quality profile
ICCC

IMMUCELL CORP /DE/

47
AI score
Similar quality profile

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put FONR on your watchlist

Track score changes the day FONAR CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is FONR a good stock to buy?

13F Pro's AI-powered analysis of FONAR CORP (FONR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for FONR are available on the FONR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own FONR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling FONR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of FONAR CORP's investment landscape.